920.3 -4.80 (-0.52%)

Related News for GLENMARK

F&O stocks: Trent, Glenmark Pharma among 5 stocks with short buildup

 23 Feb 01:24 PM

Coming to the buildup of fresh short positions, when the stock prices move downward and open interest on the counter increases, it is taken as a sign of a short build-up.

Accumulate Glenmark Pharmaceuticals; target of Rs 984: KR Choksey

 23 Feb 08:16 AM

KR Choksey recommended Accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 984 in its research report dated February 22, 2024.

Trade Spotlight | How you should deal in Gujarat Ambuja Exports, Craftsman Automation, Glenmark Pharma today

 21 Feb 06:00 AM

Glenmark Pharma formed bullish candlestick pattern on the daily scale with above average volumes. The stock showed nice recovery in last four days after falling closer to 200-day EMA, and now traded above all key moving averages.

Nirma to raise Rs 3,500 cr via bonds, pay upto 8.5%

 21 Feb 05:52 AM

Nirma entered into a deal with listed Glenmark Pharmaceuticals in September 2023 to buy a 75% stake in Glenmark Life Sciences for ₹5,650 crore. Nirma plans to fund the acquisition by the end of the current fiscal year.

Reduce Glenmark Pharmaceuticals, target price Rs 780: ICICI Securities

 20 Feb 10:27 AM

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023.

Hot Stocks: Brokerage view on Kotak Mahindra, Glenmark Pharma, Biocon and RIL

 20 Feb 10:23 AM

The risk-to-reward ratio is unfavourable at current levels. Earnings downgrades will continue due to a lack of new launches.

Pharma stocks make strong moves on robust results, positive outlook; Natco zooms 14%

 16 Feb 01:35 PM

Shares of Natco, Glenmark and Aurobindo Pharma are up 14, 10 and 2 percent respectively in the session.

BPCL, Glenmark Pharma among 5 stocks with long buildup

 16 Feb 12:43 PM

BPCL, Glenmark Pharma among 5 stocks with long buildup

 16 Feb 12:17 PM

Glenmark Pharma zooms 10% on positive management commentary

 16 Feb 12:03 PM

Glenmark Pharma aims to turn cash positive by the end of the current fiscal. The drugmaker also expects respiratory and injectables to be the major contributors in FY25